Диссертация (1139785), страница 24
Текст из файла (страница 24)
/ PEP–CHF Investigators The perindoprilin elderly people with chronic heart failure (PEP–CHF) study // Eur Heart J. 2006.27(19):2338–2345.78. Cleland JG, Pennell DJ, Ray SG et al. / Myocardial viability as a determinant of theejection fraction response to carvedilol in patients with heart failure (CHRISTMAStrial): randomised controlled trial // Lancet. 2003.362 (9377):14-21.79. Cohn Jn, Johnson G, Ziesche S et al. /A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure // N Engl J Med.1991;325 (5):303–310.80.
Cohn JN, Levine TB, Olivari MT et al. / Plasma norepinephrine as a guide toprognosis in patients with chronic congestive heart failure // N Engl J Med. 1984.311(13):819–823.81. Cohn JN, Ziesche S, Smith R et al. / Effect of the calcium antagonist felodipine assupplementary vasodilator therapy in patients with chronic heart failure treated withenalapril: V-HeFT III.
Vasodilator-Heart Failure Trial (V-HeFT) Study Group //Circulation 1997.96:856–863.82. David D, Jallad N, Germino W et al. / A comparison of the cough profile offosinopril and enalapril in hypertensive patients with history of ACE inhibitorassociated cough // Am J Ther. 1995.2 (10):806–813.83. Dickstein K, Cohen-Solal A, Filippatos G et al. / ESC guidelines for the diagnosisand treatment of acute and chronic heart failure 2008: the Task Force for the diagnosisand treatment of acute and chronic heart failure 2008 of the European Society ofCardiology.
Developed in collaboration with the Heart Failure Association of the ESC(HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) //Eur J Heart Fail 2008.10:933–989.84. Dickstein K, Kjekshus J / OPTIMAAL Steering Committee of the OPTIMAALStudy Group. Effects of losartan and captopril on mortality and morbidity in high-risk129patients after acute myocardial infarction: the OPTIMAAL randomised trial. OptimalTrial in Myocardial Infarction with Angiotensin II Antagonist Losartan // Lancet.2002.360 (9335):752–760.85. Digitalis Investigation Group / The effect of digoxin on mortality and morbidity inpatients with heart failure // N Engl J Med 1997. 336:525–533.86.
Dunlay SM, Redfield MM, Weston SA et al. / Hospitalizations after heart failurediagnosis a community perspective // J Am Coll Cardiol. 2009.54 (18):1695–170287. du Souich P, Fradette C. / The effect and clinical consequences of hypoxia oncytochrome P450, membrane carrier proteins activity and expression // Expert OpinDrug Metab Toxicol. 2011 Sep;7(9):1083-100. doi: 10.1517/17425255.2011.586630.88. Eldesoky E. S., Mohamed H. O., Farghaly W. M. et al.
/ Study of urinary 6betahydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzymeactivity in healthy and epileptic subjects of Egyptian population // Pharmacol Res. 2005,jun; 51 (6): 575–580.89. Effect of enalapril on mortality and the development of heart failure inasymptomatic patients with reduced left ventricular ejection fractions.
The SOLVDinvestigators // N Engl J Med. 1992. 327 (10):685–691.90. Effect of enalapril on survival in patients with reduced left ventricular ejectionfractions and congestive heart failure. The SOLVD investigators // N Engl J Med. 1991.325 (5):293–302.91. Effect of ramipril on mortality and morbidity of survivors of acute myocardialinfarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy(AIRE) Study Investigators // Lancet. 1993;342 (8875):821–828.92. Effects of enalapril on mortality in severe congestive heart failure: results of theCooperative North Scandinavian Enalapril Survival Study (CONSENSUS). TheCONSENSUS Trial Study Group // N Engl J Med. 1987;316 (23):1429–143593.
Faris R, Flather M, Purcell H et al. / Current evidence supporting the role ofdiuretics in heart failure: a meta-analysis of randomized controlled trials // Int J Cardiol2002.82:149–158.13094. Faris RF, Flather M, Purcell H et al. / Diuretics for heart failure // CochraneDatabase Syst Rev 2012.2:CD003838.95. Felix CA, Walker AH, Lange BJ et al. / Association of CYP3A4 genotype withtreatment-related leukemia // Proc Natl Acad Sci U S A. 1998 Oct 27.
95(22):13176-8196. Ferguson DW, Berg WJ, Sanders JS et al. / Sympathoinhibitory responses todigitalis glycosides in heart failure patients: direct evidence from sympathetic neuralrecordings // Circulation. 1989;80 (1):65–77.97. Ferrari R. / Effects of angiotensin-converting enzyme inhibition with perindopril onleft ventricular remodeling and clinical outcome: results of the randomized Perindopriland Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study // ArchIntern Med.
2006;166 (6):659–666.98. Flather MD, Shibata MC, Coats AJ et al. / Randomized trial to determine the effectof nebivolol on mortality and cardiovascular hospital admission in elderly patients withheart failure (SENIORS) // Eur Heart J. 2005;26 (3):215–225.99. Flockhart DA. / Drug Interactions: Cytochrome P450 Drug Interaction Table //Indiana University School of Medicine (2007)100. Fotino A.D., Thompson-Paul A.M., Bazzano L.A. / Effect of coenzyme Q10supplementation on heart failure: a meta-analysis // American Journal of ClinicalNutrition. 2013;97(2):268–75. DOI:10.3945/ajcn.112.040741101.
Fox KM. / Efficacy of perindopril in reduction of cardiovascular events amongpatients with stable coronary artery disease: randomised, double-blind, placebocontrolled, multicentre trial (the EUROPA study) // Lancet. 2003;362 (9386):782–788102. Francis GS, Benedict C, Johnstone DE et al. / Comparison of neuroendocrineactivation in patients with left ventricular dysfunction with and without congestive heartfailure.
A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation // 1990; 82 (5):1724–1729.103. Freeman JV, Reynolds K, Fang M et al. / Digoxin and risk of death in adults withatrial fibrillation: the ATRIA-CVRN Study // Circ Arrhythmia Electrophysiol 2015;8:49–58.131104. Fuat A, Murphy JJ, Hungin APS et al. / The diagnostic accuracy and utility of a Btype natriuretic peptide test in a community population of patients with suspected heartfailure // Br J Gen Pract.
2006; 56(526):327–33.105. Gaffney TE, Braunwald E / Importance of the adrenergic nervous system in thesupport of circulatory function in patients with congestive heart failure // Am J Med.1963;34: 320–324.106. Galteau M. M., Shamsa F. / Urinary 6beta-hydroxycortisol: a validated test forevaluating drug induction or drug inhibition mediated through CYP3A in humans and inanimals // Eur. J. Clin. Pharmacol.
- 2003, dec; 59 (10): 713–733.107. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. / Overviewof randomized trials of angiotensin-converting enzyme inhibitors on mortality andmorbidity in patients with heart failure JAMA // 1995. 273 (18):1450–1456.108. Garg R, Yusuf S.
/ Overview of randomized trials of angiotensin-convertingenzyme inhibitors on mortality and morbidity in patients with heart failure // JAMA1995. 273:1450–1456.109. Gerber Y, Weston SA, Redfield MM et al. / A contemporary appraisal of the heartfailure epidemic in Olmsted County, Minnesota, 2000 to 2010 // JAMA Intern Med2015;175:996–1004.110. Ghali JK; Piña IL;. Gottlieb SS et al. / Metoprolol CR/XL in Female Patients withHeart Failure Analysis of the Experience in Metoprolol Extended-Release RandomizedIntervention Trial in Heart Failure (MERIT–HF) // Circulation. 2002;105 (13):1585–1591.111.
Gheorghiade M, Ferguson D. / Digoxin: a neurohormonal modulator in heartfailure? // Circulation. 1991;84 (5):2181–2186.112. Gheorghiade M , Shah AN, Vaduganathan et al. / Recognizing hospitalized heartfailure as an entity and developing new therapies to improve outcomes: academics’,clinicians’, industry's, regulators’, and payers’ perspectives // Heart Fail Clin2013;9:285–290, v–vi.132113. Giles TD, Katz R, Sullivan JM et al. / Short– and long-acting angiotensinconverting enzyme inhibitors: a randomized trial of lisinopril versus captopril in thetreatment of congestive heart failure // J Am Coll Cardiol.
1989;13 (6):1240–1247.114. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and togetheron 6week mortality and ventricular function after acute myocardial infarction. GruppoItaliano per lo Studio della Sopravvivenza nell’infarto Miocardico // Lancet. 1994;343(8906):1115–1122.115. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S. / Diltiazem increases late-onsetcongestive heart failure in postinfarction patients with early reduction in ejectionfraction. The Adverse Experience Committee and the Multicenter DiltiazemPostinfarction Research Group // Circulation 1991. 83:52–60.116.
Granger CB, McMurray JJ, Yusuf S et al. / Effects of candesartan in patients withchronic heart failure and reduced left-ventricular systolic function intolerant toangiotensin-converting-enzyme inhibitors: the CHARM–Alternative trial. // Lancet.2003;362 (9386):772776.117. Greenbaum R, Zucchelli P, Caspi A et al. / Comparison of the pharmacokinetics offosinopril with enalaprilat and lisinopril in patients with CHF and chronic renalinsufficiency // Br J Clin Pharmacol. 2000;49 (1):23–31.118.
Guengerich FP / Mechanism-based inactivation of human liver microsomalcytochrome P-450 IIIA4 by gestodene // Chem Res Toxicol. 1990 Jul-Aug;3(4):363-71.119. Hall D, Zeitler H, Rudolph W. / Counteraction of the vasodilator effects ofenalapril by aspirin in severe heart failure // J Am Coll Cardiol. 1992;20 (7):1549–1555.120. Harjai KJ, Solis S, Prasad A, Loupe J. / Use of aspirin in conjunction withangiotensin-converting enzyme inhibitors does not worsen long-term survival in heartfailure // Int J Cardiol. 2003;88 (2–3):207–214.121.
Higgins CB, Vatner SF, Braunwald E. / Postprandial redistribution of regionalblood flow at rest and during exercise in conscious dogs with experimental heart failure// Am J Cardiol. 1974 Sep;34(3):318-324.133122. Hinchliffe E, Carter S et al. / Quantitation of aldosterone in human plasma byultra-high performance liquid chromatography tandem mass spectrometry // JChromatogr B Analyt Technol Biomed Life Sci 2013; Jan 15: 19-23.123. Hu LJ, Chen YQ, Deng SB et al. / Additional use of an aldosterone antagonist inpatients with mild to moderate chronic heart failure: a systematic review and metaanalysis // Br J Clin Pharmacol. 2013;75 (5):1202–1212.124.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
